Analytical Data
-
基因名
FSTL5
-
简介
FSTL5 is an extracellular matrix-secreted protein. FSTL5 promotes cell proliferation and survival by influencing the Wnt/β-catenin signaling pathway in liver cancer and inhibits the progression of liver cancer by inducing Caspase-dependent apoptosis and regulating Bcl-2 family proteins. FSTL5 Protein, Human (HEK293, Fc) is the recombinant human-derived FSTL5 protein, expressed by HEK293 , with C-hFc labeled tag.
- Application
-
别名
Follistatin-related protein 5; Follistatin-like protein 5; KIAA1263
-
种属
Human
-
表达系统
HEK293
-
标签
C-hFc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8N475-1
-
表达区间
R21-A847
-
蛋白长度
Full Length of Isoform-1 Mature Protein
-
分子量
118 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FSTL5 (Follistatin-like 5) is a secreted glycoprotein that plays crucial roles in various physiological and pathological processes, including muscle development, tissue repair, and inflammation. Research has shown that FSTL5 is involved in the regulation of myogenesis and has potential implications in muscle degenerative diseases. Additionally, it has been implicated in the modulation of metabolic processes and the protective responses of various tissues to stress. The study of recombinant FSTL5 protein has garnered interest due to its therapeutic potential in regenerative medicine and obesity-related disorders. Understanding the structure and function of FSTL5 at the molecular level can provide insights into its biological activities and interactions with other signaling pathways, potentially leading to novel treatment strategies. The increasing prevalence of muscle-wasting conditions and metabolic syndromes has further motivated researchers to explore the role of FSTL5 in these contexts. Recent advances in biotechnology have facilitated the production of recombinant FSTL5, allowing for detailed studies of its mechanism of action and effects in various cell types. This research is essential for elucidating the full spectrum of FSTL5's effects on health and disease, paving the way for innovative therapeutic approaches that harness its protective and regenerative capabilities.
